Table 2 Obstetric history and somatometric characteristics of patients included in the study
From: Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission
Group 1 | Group 2A | Group 2B | Group 2C | |
|---|---|---|---|---|
No. patients | 169 | 31 | 38 | 79 |
Gestational age, weeks, mean (SD) | 36.2 (3.7) | 34.5 (5.4) | 35.2 (4.8) | 30.3 (6.2) |
Weight at birth, g., mean (SD) | 2622 (860) | 2496 (1107) | 2573 (997) | 1542 (880) |
GBS colonisation, no. (%) | 44 (26.0) | 13 (41.9) | 0 (0) | 11 (13.9) |
Prenatal steroid exposure, no. (%) | 40 (23.7) | 9 (29.0) | 9 (23.7) | 38 (48.1) |
Membrane rupture > 18 h, no. (%) | 70 (41.4) | 18 (22.8) | 5 (13.2) | 11 (35.5) |
Intrapartum fever, no. (%) | 15 (8.9) | 7 (22.6) | 8 (21.1) | 3 (3.8) |
Chorioamnionitis, no. (%) | 10 (5.9) | 4 (12.9) | 3 (7.9) | 8 (10.1) |
Intrapartum antibiotics, no. (%) | 105 (62.1) | 15 (48.4) | 12 (31.6) | 22 (27.8) |
Resuscitation at birth, no. (%) | 10 (5.9) | 8 (25.8) | 8 (21.1) | 33 (41.8) |
Males, no. (%) | 93 (55.0) | 15 (48.4) | 16 (42.1) | 43 (54.4) |